PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
09-Sep-2024 Anocca Presents Data at ESMO Congress on Preclinical Development of its TCR-T Cell Therapies for Cancer Anocca
09-Sep-2024 HUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2024 and the 2024 World Conference of Lung Cancer HUTCHMED
09-Sep-2024 Transgene and BioInvent to Present Promising Initial Phase I/IIa Data on Oncolytic Virus, BT-001, at ESMO 2024 Transgene and BioInvent
09-Sep-2024 SMC accepts bispecific antibody TECVAYLI®▼ (teclistamab) for eligible patients with relapsed and refractory multiple myeloma Johnson & Johnson
09-Sep-2024 Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences and Enzolytics, Inc. Execute Three Year Agreement AccessWire
09-Sep-2024 Ankle & Foot Centers of America Gets Athletes Back on the Field AccessWire
09-Sep-2024 Medholdings Group Inc. Acquires MedSmart Wellness Centers AccessWire
09-Sep-2024 The Center for Immunology Science and Immunology Diagnostics Announce a Major Breakthrough Discovery: DNA-Based Proof of the Disease of Fibromyalgia Newswire
09-Sep-2024 Secarna Pharmaceuticals will present data at 6th Inflammasome Therapeutics Summit demonstrating the potential of ASOs to target the expression of NLRP3 Secarna Pharmaceuticals GmbH & Co. KG
09-Sep-2024 Registration Is Now Open For Tribe Public's Webinar Event "Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity" Featuring Modular Medical CEO On Wednesday, September 11, 2024 AccessWire
09-Sep-2024 The Center for Immunology Science and Immunology Diagnostics Announce a Major Breakthrough Discovery: DNA-Based Proof of the Disease of Fibromyalgia AccessWire
09-Sep-2024 Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis AccessWire
09-Sep-2024 CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress AccessWire
09-Sep-2024 CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress CureVac
09-Sep-2024 Moderna’s Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada AccessWire
09-Sep-2024 Meso Numismatics Announces Cellgenic’s Sponsorship of Three Prominent Regenerative Medicine Events in Peru This September Newswire
09-Sep-2024 Interactive Strength Inc. (Nasdaq: TRNR) to Present at the H.C. Wainwright 26th Annual Global Investment Conference and Meet Institutional Investors in New York from September 9th to 11th AccessWire
09-Sep-2024 Sale of Gentronix to Danish group provides an exit for investor Mercia Ventures Mercia Ventures
09-Sep-2024 Provepharm launches Blumyne™ surgical dye in UK Andrew Lloyd Associates
09-Sep-2024 Animal Feed Enzymes Market Growth, Trends, and Forecast: Key Insights and Projections Till 2032 Ameco Research